Contracts › HHSO100201700020C
HHSO100201700020C: Igf::Ot::Igf - Regeneron Other Transaction Authority (OTA) Award
Awarded to Regeneron Pharmaceuticals Inc by Office of Assistant Secretary for Preparedness and Response.
$278.8Mobligated
$359.6Mpotential value
25 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HHSO100201700020C |
|---|---|
| Awardee | Regeneron Pharmaceuticals Inc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541711 Research and Development in Biotechnology |
| PSC | AN13 Health R&D Services; Health Care Services; Experimental Development |
| Place of performance | NY |
| Offers received | 1 |
| Period of performance | 21 September 2017 to 25 September 2027 |
| Potential end | 25 September 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541711 contracts · All expiring contracts · USASpending record